NovioGendix

NovioGendix is a Swiss molecular diagnostics company developing a non-invasive liquid biopsy test for prostate cancer

Biotech & Life Sciences

Sector

Seed

Stage

Healthcare diagnostics

Model

01Company Overview

NovioGendix is a Swiss molecular diagnostics company developing a non-invasive liquid biopsy test for prostate cancer.

02Backed By1 investor

03Similar Companies

BT

Billion to One

Biotech & Life Sciences

→

M

R

B

DC

04Startup DNA

6

signals

Sectors
Business Model
Technology